Kintara Therapeutics Announces Record Date for CVR Issuance in Connection with the Proposed Merger with TuHURA Biosciences Expected to Close on October 18, 2024

Kintara Therapeutics, Inc. (“Kintara”) (Nasdaq: KTRA), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced a record date of October 17, 2024 (the “Record Date”) for the issuance of Contingent Value Rights (“CVRs”) to stockholders of record of Kintara as of the Record Date. As previously disclosed, in April […]

Innovative Eyewear Launches First-Ever Generative AI Eyewear Fashion Show

Innovative Eyewear (NASDAQ: LUCY; LUCYW), the developer of ChatGPT-enabled smart eyewear under the Lucyd®, Nautica®, Eddie Bauer®, and Reebok® brands, today announced the launch of the first generative AI fashion show for eyewear. In this striking digital performance, AI-generated models flaunt the latest real smart eyewear collections from Lucyd, including its collaborative collections with Reebok,

Germfree acquires Arcoplast to expand turnkey facility solutions and expand market reach through superior architectural finishes

— Arcoplast’s unmatched architectural finishes meet the highest standards for cleanability, durability, and sustainability for controlled environments — Acquisition supports Germfree’s expansion beyond modular and mobile applications and provides growth pathways in biopharma, ATMPs, compounding pharmacy, radiopharmacy, biocontainment, radiology, and food and beverage market segments Germfree, a pioneering leader in modular and mobile cleanroom infrastructure,

LOTTE HOTELS & RESORTS migrates to Sabre SynXis Central Reservations System

South Korea’s largest hotel group is deploying an extensive suite of Sabre Hospitality technology across its brands to further enhance distribution, reservation management, and guest experience capabilities Sabre Hospitality, a division of Sabre Corporation(NASDAQ: SABR), a leading software and technology provider that powers the global travel industry, is now the primary reservation platform for LOTTE

First Watch Restaurant Group, Inc. Provides Status of Company Restaurants Affected by Hurricane Milton

BRADENTON, Fla., Oct. 14, 2024 (GLOBE NEWSWIRE) — First Watch Restaurant Group, Inc. (NASDAQ: FWRG) (“First Watch” or the “Company”) provides the following information regarding Hurricane Milton. From October 8, 2024 through October 13, 2024, 85 Company-owned restaurants in Hurricane Milton’s path were closed at least one business day for employee safety, storm preparation, utility

Linkage Global Inc Appoints New Chief Financial Officer

Tokyo Japan, Oct. 14, 2024 (GLOBE NEWSWIRE) — Linkage Global Inc (the “Company” or “Linkage”), (NASDAQ: LGCB), a cross-border e-commerce integrated services provider headquartered in Japan, today announced the appointment of Mr. Hanson Ji as Chief Financial Officer, effective October 07, 2024. Mr. Hanson Ji has nearly 10 years of experience in the domains of

QKS Group Introduces Competitive Intelligence Solutions Equipping Businesses with Competitive Edge to Excel

Middleton, Massachusetts, Oct. 14, 2024 (GLOBE NEWSWIRE) — QKS Group has announced the launch of its innovative Competitive Intelligence & Strategy subscription service. The service is designed to equip businesses with critical insights and strategic guidance across more than 220 ICT markets. This new offering marks a significant milestone in QKS’s rebranding journey, reflecting the

Cannabis Testing Market to Witness 13.5% CAGR by 2031, Report by SkyQuest Technology

Westford, USA, Oct. 14, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that Cannabis Testing Market will attain the value of USD 21.9 Billion by 2031, with a CAGR of 13.5% during the forecast period (2024-2031). The use of cannabis in the treatment of several neurological and psychiatric conditions has also increased dramatically along with the increasing

Aprea Therapeutics to Present at Maxim 2024 Healthcare Virtual Summit

DOYLESTOWN, Pa., Oct. 14, 2024 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company focused on precision oncology through synthetic lethality, today announced that Dr. Oren Gilad, President and CEO, will participate in two presentations at the Maxim Healthcare Virtual Summit, to take place October 15 to 17,

Scroll to Top